Catalyst Pharmaceutical Inc.

$31.33
USD
Last updated on --.
24h volume1.57M
24h highest31.3450 USD
24h lowest31.2400 USD
24h Price movement+0.22%

CPRX recent prices

24 Hours
+0.22%+$0.07
30 days
+6.73%+$1.970
60 days
+33.50%+$7.840
90 days
+25.66%+$6.380

Key data

Previous close31.2600 USD
Market cap3.82B USD
Volume1.57M
P/E ratio17.280000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)1.8100 USD
Net income (FY)221.32M USD
Revenue (FY)596.96M USD
Last report dateMay 11, 2026

About Catalyst Pharmaceutical Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersCORAL GABLES
Employees (FY)182.00
Revenue per employee (FY)3.28M USD
Net income per employee (FY)1.22M USD
Listed onNasdaq
Official website

CPRX conversion tables

CPRXCPRX
USDUSD
0.5 CPRX15.66 USD
1 CPRX31.33 USD
5 CPRX156.65 USD
10 CPRX313.3 USD
USDUSD
CPRXCPRX
0.5 USD0.015959 CPRX
1 USD0.031918 CPRX
5 USD0.15959 CPRX
10 USD0.31918 CPRX

FAQ

CPRX is trading at $31.33, +0.22% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CPRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CPRX is currently trading at $31.33, +0.22% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CPRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CPRX's P/E ratio is currently 17.280000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CPRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CPRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Catalyst Pharmaceutical Inc.'s market cap is currently 3.82B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.57M
24h highest31.3450 USD
24h lowest31.2400 USD
24h Price movement+0.22%
CPRXCPRX
USDUSD
Start trade with CPRX Perpetual